Molecular mechanisms of anti-angiogenic effect of curcumin
Publication type: Journal Article
Publication date: 2002-10-21
scimago Q2
wos Q3
SJR: 0.748
CiteScore: 4.9
Impact factor: 2.2
ISSN: 0006291X, 10902104
PubMed ID:
12359244
Biochemistry
Molecular Biology
Cell Biology
Biophysics
Abstract
Modulation of pathological angiogenesis by curcumin (diferuloylmethane), the active principle of turmeric, seems to be an important possibility meriting mechanistic investigations. In this report, we have studied the effect of curcumin on the growth of Ehrlich ascites tumor cells and endothelial cells in vitro. Further, regulation of tumor angiogenesis by modulation of angiogenic ligands and their receptor gene expression in tumor and endothelial cells, respectively, by curcumin was investigated. Curcumin, when injected intraperitoneally (i.p) into mice, effectively decreased the formation of ascites fluid by 66% in EAT bearing mice in vivo. Reduction in the number of EAT cells and human umbelical vein endothelial cells (HUVECs) in vitro by curcumin, without being cytotoxic to these cells, is attributed to induction of apoptosis by curcumin, as is evident by an increase in cells with fractional DNA content seen in our results on FACS analysis. However, curcumin had no effect on the growth of NIH3T3 cells. Curcumin proved to be a potent angioinhibitory compound, as demonstrated by inhibition of angiogenesis in two in vivo angiogenesis assay systems, viz. peritoneal angiogenesis and chorioallantoic membrane assay. The angioinhibitory effect of curcumin in vivo was corroborated by the results on down-regulation of the expression of proangiogenic genes, in EAT, NIH3T3, and endothelial cells by curcumin. Our results on Northern blot analysis clearly indicated a time-dependent (0-24h) inhibition by curcumin of VEGF, angiopoietin 1 and 2 gene expression in EAT cells, VEGF and angiopoietin 1 gene expression in NIH3T3 cells, and KDR gene expression in HUVECs. Further, decreased VEGF levels in conditioned media from cells treated with various doses of curcumin (1 microM-1mM) for various time periods (0-24h) confirm its angioinhibitory action at the level of gene expression. Because of its non-toxic nature, curcumin could be further developed to treat chronic diseases that are associated with extensive neovascularization.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
|
|
|
Bioorganic and Medicinal Chemistry Letters
5 publications, 2.53%
|
|
|
European Journal of Pharmacology
4 publications, 2.02%
|
|
|
Cancer Letters
4 publications, 2.02%
|
|
|
Nutrition and Cancer
4 publications, 2.02%
|
|
|
Oncotarget
3 publications, 1.52%
|
|
|
Tumor Biology
3 publications, 1.52%
|
|
|
Phytomedicine
3 publications, 1.52%
|
|
|
Bioorganic and Medicinal Chemistry
3 publications, 1.52%
|
|
|
RSC Advances
3 publications, 1.52%
|
|
|
Biochemical and Biophysical Research Communications
2 publications, 1.01%
|
|
|
Trends in Food Science and Technology
2 publications, 1.01%
|
|
|
Nutrition Research
2 publications, 1.01%
|
|
|
Seminars in Oncology
2 publications, 1.01%
|
|
|
Nutrients
2 publications, 1.01%
|
|
|
International Journal of Molecular Sciences
2 publications, 1.01%
|
|
|
Pharmaceutics
2 publications, 1.01%
|
|
|
Polymers
2 publications, 1.01%
|
|
|
Frontiers in Cell and Developmental Biology
2 publications, 1.01%
|
|
|
BMC Cancer
2 publications, 1.01%
|
|
|
Medicinal Chemistry Research
2 publications, 1.01%
|
|
|
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy
2 publications, 1.01%
|
|
|
Life Sciences
2 publications, 1.01%
|
|
|
Carbohydrate Polymers
2 publications, 1.01%
|
|
|
Journal of Cellular Physiology
2 publications, 1.01%
|
|
|
Molecular Nutrition and Food Research
2 publications, 1.01%
|
|
|
ACS applied materials & interfaces
2 publications, 1.01%
|
|
|
Clinical Research and Regulatory Affairs
2 publications, 1.01%
|
|
|
Advances in Experimental Medicine and Biology
2 publications, 1.01%
|
|
|
Acupuncture and Moxibustion as an Evidence-based Therapy for Cancer
2 publications, 1.01%
|
|
|
1
2
3
4
5
|
Publishers
|
10
20
30
40
50
60
70
|
|
|
Elsevier
68 publications, 34.34%
|
|
|
Springer Nature
24 publications, 12.12%
|
|
|
Wiley
17 publications, 8.59%
|
|
|
MDPI
14 publications, 7.07%
|
|
|
Taylor & Francis
14 publications, 7.07%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
6 publications, 3.03%
|
|
|
SAGE
5 publications, 2.53%
|
|
|
American Chemical Society (ACS)
4 publications, 2.02%
|
|
|
Royal Society of Chemistry (RSC)
4 publications, 2.02%
|
|
|
Spandidos Publications
3 publications, 1.52%
|
|
|
Bentham Science Publishers Ltd.
3 publications, 1.52%
|
|
|
Impact Journals
3 publications, 1.52%
|
|
|
Frontiers Media S.A.
3 publications, 1.52%
|
|
|
Mary Ann Liebert
2 publications, 1.01%
|
|
|
Oxford University Press
2 publications, 1.01%
|
|
|
Hindawi Limited
2 publications, 1.01%
|
|
|
American Society for Pharmacology and Experimental Therapeutics
1 publication, 0.51%
|
|
|
The Royal Society
1 publication, 0.51%
|
|
|
Maad Rayan Publishing Company
1 publication, 0.51%
|
|
|
Pleiades Publishing
1 publication, 0.51%
|
|
|
IntechOpen
1 publication, 0.51%
|
|
|
Institute of Biochemistry
1 publication, 0.51%
|
|
|
Asian Pacific Organization for Cancer Prevention
1 publication, 0.51%
|
|
|
Japanese Society for Food Science and Technology
1 publication, 0.51%
|
|
|
Walter de Gruyter
1 publication, 0.51%
|
|
|
Index Copernicus
1 publication, 0.51%
|
|
|
American Association for Cancer Research (AACR)
1 publication, 0.51%
|
|
|
American Physiological Society
1 publication, 0.51%
|
|
|
American Society of Clinical Oncology (ASCO)
1 publication, 0.51%
|
|
|
10
20
30
40
50
60
70
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
198
Total citations:
198
Citations from 2024:
7
(3.54%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Gururaj A. E. et al. Molecular mechanisms of anti-angiogenic effect of curcumin // Biochemical and Biophysical Research Communications. 2002. Vol. 297. No. 4. pp. 934-942.
GOST all authors (up to 50)
Copy
Gururaj A. E., Belakavadi M., Venkatesh D. A., Marmé D., Salimath B. P. Molecular mechanisms of anti-angiogenic effect of curcumin // Biochemical and Biophysical Research Communications. 2002. Vol. 297. No. 4. pp. 934-942.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/S0006-291X(02)02306-9
UR - https://doi.org/10.1016/S0006-291X(02)02306-9
TI - Molecular mechanisms of anti-angiogenic effect of curcumin
T2 - Biochemical and Biophysical Research Communications
AU - Gururaj, Anupama E.
AU - Belakavadi, Madesh
AU - Venkatesh, Deepak A.
AU - Marmé, Dieter
AU - Salimath, Bharathi P.
PY - 2002
DA - 2002/10/21
PB - Elsevier
SP - 934-942
IS - 4
VL - 297
PMID - 12359244
SN - 0006-291X
SN - 1090-2104
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2002_Gururaj,
author = {Anupama E. Gururaj and Madesh Belakavadi and Deepak A. Venkatesh and Dieter Marmé and Bharathi P. Salimath},
title = {Molecular mechanisms of anti-angiogenic effect of curcumin},
journal = {Biochemical and Biophysical Research Communications},
year = {2002},
volume = {297},
publisher = {Elsevier},
month = {oct},
url = {https://doi.org/10.1016/S0006-291X(02)02306-9},
number = {4},
pages = {934--942},
doi = {10.1016/S0006-291X(02)02306-9}
}
Cite this
MLA
Copy
Gururaj, Anupama E., et al. “Molecular mechanisms of anti-angiogenic effect of curcumin.” Biochemical and Biophysical Research Communications, vol. 297, no. 4, Oct. 2002, pp. 934-942. https://doi.org/10.1016/S0006-291X(02)02306-9.